Literature DB >> 1584757

Phosphorylation sites in the amino-terminal region of mouse p53.

Y Wang1, W Eckhart.   

Abstract

Phosphorylation is an attractive mechanism for regulating the functions of p53. The p34cdc2 kinase, which is involved in regulation of the cell cycle, phosphorylates serine-315 of human p53 in vitro. Casein kinase II phosphorylates serine-389 of mouse p53 in vitro. The amino-terminal region of mouse p53 contains a cluster of potential serine phosphorylation sites. Those sites have been proposed to be sites for phosphorylation by a double-stranded DNA-dependent kinase (DNA-PK) from HeLa cells and can be dephosphorylated by protein phosphatase 2A. To identify in vivo phosphorylation sites in the amino-terminal region of mouse p53, we mutated potential phosphorylation sites and analyzed the mutant proteins by tryptic phosphopeptide mapping. We identified serine-7, -9, -18, and -37 as in vivo phosphorylation sites. We further showed that mouse p53 expressed in bacteria is phosphorylated by DNA-PK on amino-terminal serine residues in vitro.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584757      PMCID: PMC49055          DOI: 10.1073/pnas.89.10.4231

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

2.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates.

Authors:  W J Boyle; P van der Geer; T Hunter
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen.

Authors:  E H Wang; P N Friedman; C Prives
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

5.  Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells.

Authors:  A Samad; C W Anderson; R B Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues.

Authors:  S P Lees-Miller; C W Anderson
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

Review 7.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 9.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II.

Authors:  S P Lees-Miller; C W Anderson
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

View more
  18 in total

1.  Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

Authors:  D M Milne; R H Palmer; D W Meek
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Occurrence of acute myeloid leukemia in hydroxyurea-treated sickle cell disease patient.

Authors:  Samuel Regan; Xuebin Yang; Niklas K Finnberg; Wafik S El-Deiry; Jeffrey J Pu
Journal:  Cancer Biol Ther       Date:  2019-08-18       Impact factor: 4.742

3.  Adeno-associated virus type 2 modulates the host DNA damage response induced by herpes simplex virus 1 during coinfection.

Authors:  Rebecca Vogel; Michael Seyffert; Regina Strasser; Anna P de Oliveira; Christiane Dresch; Daniel L Glauser; Nelly Jolinon; Anna Salvetti; Matthew D Weitzman; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.

Authors:  O Filhol; J Baudier; E M Chambaz; C Cochet
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

5.  Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo.

Authors:  M K Lee; W M Tong; Z Q Wang; K Sabapathy
Journal:  Cell Death Differ       Date:  2010-07-30       Impact factor: 15.828

6.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.

Authors:  Marie P Fogarty; Eric J Downer; Veronica Campbell
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

8.  Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.

Authors:  S J Ullrich; K Sakaguchi; S P Lees-Miller; M Fiscella; W E Mercer; C W Anderson; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  c-Jun is phosphorylated by the DNA-dependent protein kinase in vitro; definition of the minimal kinase recognition motif.

Authors:  A J Bannister; T M Gottlieb; T Kouzarides; S P Jackson
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

10.  Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example.

Authors:  Nurcan Tuncbag; Gozde Kar; Attila Gursoy; Ozlem Keskin; Ruth Nussinov
Journal:  Mol Biosyst       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.